Article
RPRM (Reprimo) triggers SCF <sup>FBXW11</sup> -mediated DNA-PKcs degradation to block non-homologous end joining and radiosensitize tumors
2025-12-16
Abstract excerpt
Targeting DNA damage repair pathways represents a promising strategy in cancer radiotherapy, however, the limited insight into the regulation of the non-homologous end joining (NHEJ) repair pathway in cancer cells severely restricts the development of precise radiosensitization approaches. Here, we identify Reprimo (RPRM), a p53-inducible tumor suppressor, is a potent inhibitor of NHEJ in which RPRM promotes prote...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8231d62b-3f03-50ff-beac-cafad1fcd6b3
- DOI
- 10.64898/2025.12.14.694167
